Trial intelligence / Profile preview

Hemin for prevention of post-ERCP acute pancreatitis

2011-000397-59Phase 3Completed

Start: Feb 2011
Modality: Small Molecules
Countries: 1

Overview

Phase 3, randomised, double-blind trial in acute pancreatitis (AP) comparing Hemin with Placebo (2 arms). Primary endpoint: Incidence of post-ERCP acute pancreatitis. Started Feb 2011; status: completed.

Drugs

hemin

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on 2011-000397-59.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-000397-59.